William D Figg, Pharm.D.

National Cancer Institute (NCI)

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name William D Figg, Pharm.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:50 UTC. Open this list on ClinicalTrials.gov

Ph1
NCT03478904 · Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer
National Cancer Institute (NCI) · terminated · Prostate Cancer · principal investigator
Ph1
NCT03436745 · The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
National Cancer Institute (NCI) · terminated · Prostatic Neoplasms · principal investigator
N/A
NCT02810405 · Collection of Tissue Blocks or Slides From Patients With Cancer
National Cancer Institute (NCI) · completed · Tumor, Carcinogens, Neoplasm, Benign · principal investigator
N/A
NCT02706652 · Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
National Cancer Institute (NCI) · terminated · Cancer · principal investigator
N/A
NCT02154022 · Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity
National Cancer Institute (NCI) · enrolling by invitation · Cancer, Solid Tumors, Neoplasm · principal investigator
N/A
NCT01441089 · Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Cancer Institute (NCI) · recruiting · Prostate Cancer, Breast Cancer, Lung Cancer · principal investigator
N/A
NCT00923221 · Collection of Blood From Patients With Prostate Cancer
National Cancer Institute (NCI) · recruiting · Cancer Of Prostate, Prostate Cancer, Prostatic Neoplasms · principal investigator
N/A
NCT00880503 · Collection of Tissue Samples for Study of Multidrug Resistance
National Cancer Institute (NCI) · completed · Breast Carcinoma, Breast Cancer, Medullary Thyroid Carcinoma · principal investigator
N/A
NCT00339664 · Analyses of Human Samples Collected in Clinical Trials
National Cancer Institute (NCI) · completed · Leukemia, Myeloid, Neoplasm Metastasis, Leukemia, Lymphoid · principal investigator
N/A
NCT00341939 · Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
National Cancer Institute (NCI) · completed · Prostate Cancer, Breast Cancer, Cutaneous T-Cell Lymphoma · principal investigator
N/A
NCT00026663 · Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
National Cancer Institute (NCI) · completed · Renal Cell Carcinoma, Lung Carcinoma, Cervical Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 09:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name.